Milestone Pharmaceuticals gets NMPA approval for Etripamil nasal spray in China
Milestone Pharmaceuticals said China’s NMPA approved its etripamil nasal spray for PSVT, the first Etripamil regulatory approval outside the United States.
Story updates
01:37:35 PM UTC
SquawkNews
Everest Medicines to Lead Commercialization in Greater China, Bringing Novel Innovation to Estimated 3-6 Million Chinese Patients with PSVTApproval Triggers $2.0 Million Payment to Milestone PharmaceuticalsMONTREAL and CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals I…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.